Ernexa Therapeutics Inc. Income Taxes Receivable, Current
Ernexa Therapeutics Inc. (ERNA) had Income Taxes Receivable, Current of $23.30 thousand as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes
us-gaap:IncomeTaxesReceivable · last filed 2021-11-12
- 2021-09-30: Income Taxes Receivable, Current $23.30K.
- 2021-06-30: Income Taxes Receivable, Current $23.30K.
- 2021-03-31: Income Taxes Receivable, Current $28.49K.
- 2020-12-31: Income Taxes Receivable, Current $0.00.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2021-09-30 | $23.30K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $23.30K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $28.49K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-12 |
| 2020-09-30 | $13.00K 10-Q · filed 2020-11-13 |
| 2019-06-30 | $8.00K 10-Q · filed 2019-08-12 |
| 2017-06-30 | $7.00K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |